ResearcherTongji UniversityNo recent work listed

Zhi‐Qi Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5909-0408; OpenAlex author ID A5100765054. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2022: 1 paper

Papers 1

RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway. Co-author DOI 10.1186/s12964-022-00974-5 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dachuan Qi · 1 shared paper, 2022 · strength 0.14
- Paper RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway. DOI 10.1186/s12964-022-00974-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.